Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors (clinicaltrials.gov) - Oct 20, 2026 - P2 | N=70 | Recruiting | Sponsor: National Cancer Institute (NCI) | Trial completion date: Jul 2027 ➔ Sep 2032 | Trial primary completion date: Jul 2027 ➔ Sep 2032
Trial completion date • Trial primary completion date • Endocrine Cancer • Lung Cancer • Neuroendocrine Tumor • Oncology • Small Cell Lung Cancer • Solid Tumor • SSTR
|